Session IV: KRAS/BRAF and Other Emerging Markers

Session Moderator(s)

• 

  Corey Langer, MD, FACP

  Abramson Cancer Center, Hospital of the University of Pennsylvania

Presenter(s)

• 

  Charu Aggarwal, MD, MPH

  Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
• 

  Rebecca Heist, MD, MPH

  Harvard Medical School, Massachusetts General Hospital
• 

  Helen Ross, MD

  Banner MD Anderson Cancer Center

Presentations:

• 9:00 AM – 9:10 AM

  Welcome and Introduction
  

  Chair: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania
• 9:10 AM – 9:25 AM

  BRAF Mutation: What is the Most Appropriate Approach?
  

  Speaker: Charu Aggarwal, MD, MPH – Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
• 9:25 AM – 9:45 AM

  KRAS Mutations: Targeting a “Defiant” Oncogene
  

  Speaker: Rebecca Heist, MD, MPH – Harvard Medical School, Massachusetts General Hospital
• 9:45 AM – 10:00 AM

  Antibody-Drug Conjugates: Is There a Place in the Management of Thoracic Cancer?
  

  Speaker: Helen J. Ross, MD – Banner MD Anderson Cancer Center
• 10:00 AM – 10:15 AM

  Q&A
  

  Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

  Panelist: Charu Aggarwal, MD, MPH – Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania

  Panelist: Rebecca Heist, MD, MPH – Harvard Medical School, Massachusetts General Hospital

  Panelist: Helen J. Ross, MD – Banner MD Anderson Cancer Center